Join host Lyndsay Malchuk on Market Frontlines as she sits down with Leo Wang, Chairman of Leo International Precision Health AG, for an eye-opening conversation about the future of proactive healthcare. Discover how Leo International is shifting healthcare from reactive to predictive by building a connected, AI-driven healthcare ecosystem. Learn about their disciplined acquisition strategy – reviewing over 200 companies, auditing 20, and selecting just six assets across five countries with a combined valuation of €111 million. Wang explains key portfolio companies like Dr. Pain, which combines Western and traditional Chinese medicine with AI-powered therapy beds that track patient movements to improve treatment efficiency, and Pasamics, a Singapore-based gene testing firm offering personalized care solutions in partnership with insurance companies. With a current market cap of only €9 million, this represents a significant undervaluation opportunity. If you’re an investor, healthcare professional, or interested in AI-driven digital transformation, this episode reveals how precision health and early detection can change everything.